Liberate Medical company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

liberatemedical.com

Founded Year

2013

Stage

Incubator/Accelerator | Alive

Total Raised

$1.49M

About Liberate Medical

Liberate Medical is a medical device company, based in Louisville, KY, that was spun out of Apellis Pharmaceuticals. Liberate aims to improve both the quality of care and reduce the cost of health care for patients who have difficulty weaning from mechanical ventilation (MV) and for patients with Chronic Obstructive Pulmonary Disease (COPD).

Liberate Medical Headquarter Location

6400 Westwind Way Suite A

Crestwood, Kentucky, 40014,

United States

833-203-4663

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Liberate Medical

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Liberate Medical in 1 CB Insights research brief, most recently on Mar 26, 2020.

Expert Collections containing Liberate Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Liberate Medical is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

9,052 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,900 items

Latest Liberate Medical News

ALung Technologies Inc and Baxter Healthcare Corp Among Leading Companies in the Respiratory Assist Devices Pipeline Products Market | Globaldata Plc

Jul 7, 2022

Number of Respiratory Assist Devices Pipeline Products, by Regulatory Path Respiratory Assist Devices Pipeline Products Market Report Scope Extensive coverage of the respiratory assist devices under development The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities The report reviews the major players involved in the development of respiratory assist devices and lists all their pipeline projects The coverage of pipeline products is based on various stages of development ranging from early development to approved/issued stage The report provides key clinical trial data of ongoing trials specific to pipeline products Recent developments in the segment/industry Reasons to Buy Formulate significant competitor information, analysis, and insights to improve R&D strategies Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage Identify and understand important and diverse types of respiratory assist devices under development Develop market-entry and market expansion strategies Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline In-depth analysis of the product’s current stage of development, territory and estimated launch date Related Reports Diagnostic and Measurement Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update – Clic k here Synthetic Meshes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update – Click here Special Coagulation Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update – Click here Image Guided Surgery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update – Click here Critical Care Ventilators Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update – Click here Respiratory Assist Devices Pipeline Products Market Overview Segments Leading Companies Advanced Respiratory Technologies LLC, ALung Technologies Inc, Baxter Healthcare Corp, Bellco Srl, Belluscura Plc, Braile Biomedica Ltda, Breethe, Inc., Case Western Reserve University, enmodes GmbH, Liberate Medical LLC, Lung Biotechnology PBC, MAQUET Cardiopulmonary AG, MC3 Inc, McGowan Institute for Regenerative Medicine, Minnesota Health Solutions Corporation, and Miromatrix Medical Inc FAQs What are the key segments in the respiratory assist devices pipeline products market? The key segments in the respiratory assist devices pipeline products market are artificial lung and respiratory assist catheter. What are the key territories in the respiratory assist devices pipeline products market? Some of the key territories in the respiratory assist devices pipeline products market are the United States, Europe, India, Japan, and Brazil. What are the regulatory paths in the respiratory assist devices pipeline products market? The regulatory paths in the respiratory assist devices pipeline products market are 510(k), PMA, CE, ICAC, and Ninsho. Which are the leading companies in the respiratory assist devices pipeline products market? Some of the leading companies in the respiratory assist devices pipeline products market are Advanced Respiratory Technologies LLC, ALung Technologies Inc, Baxter Healthcare Corp, Bellco Srl, Belluscura Plc, Braile Biomedica Ltda, Breethe, Inc., Case Western Reserve University, enmodes GmbH, Liberate Medical LLC, Lung Biotechnology PBC, MAQUET Cardiopulmonary AG, MC3 Inc, McGowan Institute for Regenerative Medicine, Minnesota Health Solutions Corporation, and Miromatrix Medical Inc. Table of Contents |1.2 List of Figures 8 2 Introduction 9 3 Products under Development 10 3.1 Respiratory Assist Devices – Pipeline Products by Stage of Development 10 3.2 Respiratory Assist Devices – Pipeline Products by Segment 11 3.3 Respiratory Assist Devices – Pipeline Products by Territory 12 3.4 Respiratory Assist Devices – Pipeline Products by Regulatory Path 13 3.5 Respiratory Assist Devices – Pipeline Products by Estimated Approval Date 14 3.6 Respiratory Assist Devices – Ongoing Clinical Trials 15 4 Respiratory Assist Devices – Pipeline Products under Development by Companies 16 4.1 Respiratory Assist Devices Companies – Pipeline Products by Stage of Development 16 4.2 Respiratory Assist Devices – Pipeline Products by Stage of Development 18 5 Respiratory Assist Devices Companies and Product Overview 20 5.1 Advanced Respiratory Technologies LLC Company Overview 20 5.1.1 Advanced Respiratory Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 20 5.2 ALung Technologies Inc Company Overview 21 5.2.1 ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 21 5.3 Baxter Healthcare Corp Company Overview 25 5.3.1 Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview 25 5.4 Bellco Srl Company Overview 28 5.4.1 Bellco Srl Pipeline Products & Ongoing Clinical Trials Overview 28 5.5 Belluscura Plc Company Overview 29 5.5.1 Belluscura Plc Pipeline Products & Ongoing Clinical Trials Overview 29 5.6 Braile Biomedica Ltda Company Overview 30 5.6.1 Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview 30 5.7 Breethe, Inc. Company Overview 31 5.7.1 Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31 5.8 Case Western Reserve University Company Overview 33 5.8.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 33 5.9 enmodes GmbH Company Overview 34 5.9.1 enmodes GmbH Pipeline Products & Ongoing Clinical Trials Overview 34 5.10 Liberate Medical LLC Company Overview 35 5.10.1 Liberate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 35 5.11 Lung Biotechnology PBC Company Overview 36 5.11.1 Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview 36 5.12 MAQUET Cardiopulmonary AG Company Overview 38 5.12.1 MAQUET Cardiopulmonary AG Pipeline Products & Ongoing Clinical Trials Overview 38 5.13 MC3 Inc Company Overview 39 5.13.1 MC3 Inc Pipeline Products & Ongoing Clinical Trials Overview 39 5.14 McGowan Institute for Regenerative Medicine Company Overview 40 5.14.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 40 5.15 Minnesota Health Solutions Corporation Company Overview 45 5.15.1 Minnesota Health Solutions Corporation Pipeline Products & Ongoing Clinical Trials Overview 45 5.16 Miromatrix Medical Inc Company Overview 46 5.16.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 46 5.17 Postgraduate Institute of Medical Education and Research Company Overview 47 5.17.1 Postgraduate Institute of Medical Education and Research Pipeline Products & Ongoing Clinical Trials Overview 47 5.18 Rice University Company Overview 48 5.18.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 48 5.19 The Charles Stark Draper Laboratory Inc Company Overview 49 5.19.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 49 5.20 TVS Group Company Overview 50 5.20.1 TVS Group Pipeline Products & Ongoing Clinical Trials Overview 50 5.21 U.S. Ann Arbor Healthcare System Company Overview 51 5.21.1 U.S. Ann Arbor Healthcare System Pipeline Products & Ongoing Clinical Trials Overview 51 5.22 University of Arizona Company Overview 52 5.22.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 52 5.23 University of California Los Angeles Company Overview 53 5.23.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 53 5.24 University of Michigan Company Overview 54 5.24.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 54 5.25 University of Pittsburgh Company Overview 55 5.25.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 55 5.26 Veterans Health Administration Company Overview 57 5.26.1 Veterans Health Administration Pipeline Products & Ongoing Clinical Trials Overview 57 5.27 X-COR Therapeutics Company Overview 59 5.27.1 X-COR Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 59 5.28 Xenios AG Company Overview 60 5.28.1 Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 60 6 Respiratory Assist Devices- Recent Developments 61 6.1 May 17, 2022: Soleno Therapeutics to Participate in the H.C. Wainwright Global Investment Conference 61 6.2 May 02, 2022: Teleflex to Host Analyst & Investor Day on May 20, 2022 61 6.3 Apr 28, 2022: Teleflex Reports First Quarter Financial Results And Full Year Outlook 61 6.4 Apr 19, 2022: Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Med 63 6.5 Apr 14, 2022: Inogen to Announce First Quarter 2022 Financial Results on May 5, 2022 63 6.6 Mar 31, 2022: Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results 64 6.7 Mar 29, 2022: Miromatrix Moves into New Headquarters Complete with In-House Manufacturing Capabilities 65 6.8 Mar 17, 2022: Miromatrix to Report Fourth Quarter and Full Year 2021 Financial Results 66 6.9 Mar 01, 2022: Miromatrix Names Jim Douglas as New Chief Financial Officer 66 6.10 Feb 24, 2022: Teleflex Announces Fourth Quarter and Full-Year 2021 Financial Results 67 6.11 Feb 08, 2022: Soleno Therapeutics to Participate in the BIO CEO & Investor Conference 68 6.12 Jan 26, 2022: Inogen to Announce Fourth Quarter 2021 Financial Results on February 24, 2022 68 6.13 Jan 05, 2022: Soleno Therapeutics to Participate in the LifeSci Partners 11th Annual Corporate Access Event 69 6.14 Nov 18, 2021: Teleflex to Participate in the 33rd Annual Virtual Piper Sandler Healthcare Conference 69 6.15 Oct 28, 2021: Teleflex Reports Third Quarter 2021 Results and Full Year Outlook 69 6.16 Oct 14, 2021: Teleflex Announces Third Quarter 2021 Earnings Conference Call Information 73 6.17 Oct 13, 2021: Inogen to Announce Third Quarter 2021 Financial Results on November 4, 2021 73 6.18 Sep 23, 2021: Soleno Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference 74 6.19 Sep 22, 2021: The international standard proposed by experts from BMC Medical in terms of high-flow respiratory therapy equipment officially released 74 6.20 Sep 01, 2021: Teleflex to Present at the Morgan Stanley 19th Annual Global Healthcare Conference 74 6.21 Aug 26, 2021: Teleflex to Present at the Wells Fargo 2021 Virtual Healthcare Conference 74 6.22 Aug 04, 2021: Inogen Announces Second Quarter 2021 Financial Results 75 6.23 Jul 29, 2021: Draper develops artificial lung technology with $4.9M U.S. army grant, earns ASAIO award 77 6.24 Jul 28, 2021: Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results 78 6.25 Jul 14, 2021: Inogen to Announce Second Quarter 2021 Financial Results on August 4, 2021 80 6.26 Jul 13, 2021: Xenios receives approval in China for ECMO devices 80 6.27 Jun 08, 2021: Inogen announces appointment of chief medical officer 81 7 Appendix 82 About us Globa l Data is a leading provider of data, analytics, and insights on the world's largest industries. In an increasingly fast-moving, complex, and uncertain world, it has never been harder for organizations and decision makers to predict and navigate the future. This is why GlobalData's mission is to help our clients to decode the future and profit from faster, more informed decisions. As a leading information services company, thousands of clients rely on GlobalData for trusted, timely, and actionable intelligence. Our solutions are designed to provide a daily edge to professionals within corporations, financial institutions, professional services, and government agencies. Media Contacts

Liberate Medical Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Liberate Medical Rank

  • When was Liberate Medical founded?

    Liberate Medical was founded in 2013.

  • Where is Liberate Medical's headquarters?

    Liberate Medical's headquarters is located at 6400 Westwind Way, Crestwood.

  • What is Liberate Medical's latest funding round?

    Liberate Medical's latest funding round is Incubator/Accelerator.

  • How much did Liberate Medical raise?

    Liberate Medical raised a total of $1.49M.

  • Who are the investors of Liberate Medical?

    Investors of Liberate Medical include XLerateHealth and Apellis Pharmaceuticals.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.